Risk estimation of neuroblastoma patients by gene expression based classification
Manuel Fischer(University of Basel), Frank Berthold(University of Cologne), Smadar Avigad(Schneider Children's Medical Center), Olivier Delattre(Institut Curie), Frank Speleman(Ghent University), Isaac Yaniv(Tel Aviv University), Holger Christiansen(Heidelberg University), Anna-Lena Weber(University Hospital Leipzig), Benedikt Brors(German Cancer Research Center), Isabelle Janoueix‐Lerosey(Inserm), Rosa Noguera(Universitat de València), André Oberthuer, B Hero(University of Cologne), Richard G. Grundy(Brain Tumour Research), Robert C. Seeger(Ottawa Hospital), Marta Piqueras(Universitat de València), Paola Scaruffi(Azienda Ospedaliera S.Maria), Thorsten Simon(University of Cologne), Alexandre Valent(Institut Gustave Roussy), Jo Vandesompele(Ghent University), Shahab Asgharzadeh(Children's Hospital of Los Angeles), Tonini Gp(Alleanza Contro il Cancro), Jessica Theißen(University Hospital Cologne), Jean Bénard(Institut Gustave Roussy), Frank Westermann(German Cancer Research Center)
Ghent University Academic Bibliography (Ghent University)
January 1, 2009
Cited by 0
Related Papers
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
|Genome biology|2002|20k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.
|Journal of Clinical Oncology|1993|2.3k
The genetic landscape of high-risk neuroblastoma
|Nature Genetics|2013|1.2k